Neuroscience News

17 new projects support preparation of future leaders in the STEM workforce.

In 2007, Stanford University neuroscientist Ben Barres published an essay comparing the experiences of female and male scientists. What made this essay noteworthy was that he wrote from personal experience.

A new study suggests that ketamine, an increasingly popular treatment for depression, has something in common with drugs like fentanyl and oxycodone.

For about a dozen years now, the drug ketamine has been a buzz word in psychiatric research circles. Many considered it the most exciting thing to emerge in decades to successfully treat treatment-resistant depression as well as other severe forms of psyc

In a new book, Stanford pain psychologist Beth Darnall offers practical tools for health care providers to help their patients reduce pain.

Sometimes the enormous success of science leads to some wrong assumptions. In the case of brain science, the advent of sophisticated brain scans opened a window to the brain as never before.

More and more Americans are reporting near-constant cannabis use, as legalization forges ahead.

Getting a sound night’s sleep is important for good health. But, sometimes older adults get much less sleep than they need. Health experts say seniors could sleep better if they made some simple changes.

Speeding up the chemical messenger’s action makes autism-modeling mice more social

The release of a single signaling chemical from a specific nerve-cell tract in a particular part of the brain, like an on/off switch, may spell the difference between sociability and social awkwardness.

Autism spectrum disorder is marked by severe social deficits. Stanford researchers were able to reverse those types of deficits in mice by activating a single brain circuit.

Stanford mechanical engineering PhD student Sean Sketch is working to better understand proprioception — in the hope of one day helping people for whom sense has been impaired by stroke or other diseases.

Neurons in the brain and body send chemical signals from one to the next. Now, scientists led by Stanford's Steven Chu are a step closer to watching those signals take shape inside individual neurons.

A Palo Alto company is teaming up with a Stanford health care network and several regional high schools for a study that will use virtual reality headsets to track eye movements to better spot concussions.

The FDA has approved the use of an implanted device that releases periodic electrical discharges in the brain to counteract seizures in people with epilepsy. In an interview, neurologist Robert Fisher described the technology and Stanford’s role in testin

Stanford psychiatric researcher Natalie Rasgon, MD, PhD, and her collaborators in a multicenter study have identified a substance, acetyl-L-choline, whose levels in the blood of people suffering from depression are correspondingly depressed.